Donald Trump’s reclassification of marijuana was welcome news to many, writes Armstrong Williams, but it won’t make America ...

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December 2025 ...

These days we see a lot of people with literacy problem inside the prison; people can’t read and write. When you ask them ...

Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

Throughout 2025, consumer purchasing data, dispensary menus, and retail trends point to a mix of long-established favorites ...

"Swearing is an easily available way to help yourself feel focused, confident and less distracted, and 'go for it' a little ...

The first is drip irrigation, pioneered by Netafim, founded in the 1960s on Kibbutz Hatzerim after engineer Simcha Blass ...

Nick Reiner, who has schizophrenia, had his medications changed prior to the killings of his parents, according to sources ...

A look inside how the hemp industry is responding to an agriculture funding provision that would cut the industry by 95%.

Get the latest U.S. stock market and healthcare sector updates, key company news, and top healthcare winners and losers.

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

Organigram Global Inc. (NASDAQ: OGI) Q4 2025 Earnings Call Transcript December 16, 2025 Organigram Global Inc. misses on ...